The vaccine, developed by the American company Moderna, has shown high efficiency after the third stage of clinical trials.
According to the data provided by the company in the report, the vaccine successfully worked in 94.5% of cases. Some patients named headaches and fatigue among the side effects. At the moment, there is also no data on how the vaccine works for the age group over 65.
However, after further testing and approval of the vaccine, the drug will not be available outside the US until the end of this year.
Previously, Beautiful Lifestyle magazine wrote about the Sputnik V vaccine, which you can read more about here.
